Analyst Downgrade Signal: SGRY from Buy to Neutral by BofA Securities
Price Target: $55>>36
Report Date: 06-15-2022
Symbol: SGRY - Surgery Partners, Inc.
Sector: Healthcare
Industry: Medical Care Facilities
Analyst Downgrade Signal: SGRY from Buy to Neutral by BofA Securities
Price Target: $55>>36
Surgery Partners, Inc. (SGRY)
310 Seven Springs Way Ste 500
Brentwood, TENNESSEE 37027
Phone: 16152345900
Website: http://www.surgerypartners.com
CEO: Mr. J. Eric Evans
NASDAQ, Nasdaq Global Select
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services, and optical services. It also operates optical laboratory that manufactures eyewear. As of March 31, 2020, the company owned or operated a portfolio of 127 surgical facilities, including 111 ambulatory surgical centers and 16 surgical hospitals in 30 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.